Korean J Pancreas Biliary Tract.  2018 Jul;23(3):139-143. 10.15279/kpba.2018.23.3.139.

Chemotherapy for Small Cell Carcinoma of Gallbladder: A Case Report

Affiliations
  • 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kyung Hee University College of Medicine, Seoul, Korea. gidrdong@hanmail.net
  • 2Division of Gastroenterology and Hepatology, Department of Internal Medicine, Dongsuwon General Hospital, Suwon, Korea.

Abstract

Small cell carcinoma (SCC) of the gallbladder is a rare disease. It is an aggressive tumor that tends to metastasis early and is associated with poor prognosis. Median overall survival is reported to be approximately 13 months. Metastatic disease has a worse prognosis, and median overall survival is reported to be approximately 4 months. A 65-year-old male patient was diagnosed with the SCC of the gallbladder and was treated with cisplatin/etoposide chemotherapy followed by radiation therapy. Here, we describe the case of the SCC of the gallbladder who survived more than 3 years followed by the review of the literatures on this disease.

Keyword

Carcinoma; Small cell; Gallbladder

MeSH Terms

Aged
Carcinoma, Small Cell*
Drug Therapy*
Gallbladder*
Humans
Male
Neoplasm Metastasis
Prognosis
Rare Diseases
Full Text Links
  • KJPBT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr